REVIEW
|
doi:10.20944/preprints202306.1421.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Oligometastases; prostate cancer; PSMA-PET; stereotaxic body radiotherapy (SBRT); oligorecurrent prostate cancer; metastasis directed therapy; clinical trials.
Online: 20 June 2023 (09:56:01 CEST)